125 related articles for article (PubMed ID: 15822194)
1. Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease.
Ducruet AP; Vogt A; Wipf P; Lazo JS
Annu Rev Pharmacol Toxicol; 2005; 45():725-50. PubMed ID: 15822194
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of the CDC25 phosphatases.
Prevost GP; Brezak MC; Goubin F; Mondesert O; Galcera MO; Quaranta M; Alby F; Lavergne O; Ducommun B
Prog Cell Cycle Res; 2003; 5():225-34. PubMed ID: 14593717
[TBL] [Abstract][Full Text] [Related]
3. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
[TBL] [Abstract][Full Text] [Related]
4. Phosphatases as targets for cancer treatment.
Lazo JS; Wipf P
Curr Opin Investig Drugs; 2009 Dec; 10(12):1297-304. PubMed ID: 19943201
[TBL] [Abstract][Full Text] [Related]
5. [Secretases as therapeutic targets for the treatment of Alzheimer's disease].
Dejaegere T; de Strooper B
Verh K Acad Geneeskd Belg; 2004; 66(1):29-58; discussion 58-9. PubMed ID: 15074081
[TBL] [Abstract][Full Text] [Related]
6. Current treatments and therapeutic targets in Alzheimer's disease.
Zlokovic BV
Adv Drug Deliv Rev; 2002 Dec; 54(12):1533-7. PubMed ID: 12453670
[No Abstract] [Full Text] [Related]
7. Serine/threonine protein phosphatases in apoptosis.
Klumpp S; Krieglstein J
Curr Opin Pharmacol; 2002 Aug; 2(4):458-62. PubMed ID: 12127881
[TBL] [Abstract][Full Text] [Related]
8. Protease inhibitors: a panacea?
Haq SK; Rabbani G; Ahmad E; Atif SM; Khan RH
J Biochem Mol Toxicol; 2010; 24(4):270-7. PubMed ID: 20135636
[TBL] [Abstract][Full Text] [Related]
9. Chemical probe development versus drug development.
Jackson MR
Methods Mol Biol; 2013; 1053():1-6. PubMed ID: 23860644
[TBL] [Abstract][Full Text] [Related]
10. Studies of small molecule interactions with protein phosphatases using biosensor technology.
Stenlund P; Frostell-Karlsson A; Karlsson OP
Anal Biochem; 2006 Jun; 353(2):217-25. PubMed ID: 16597430
[TBL] [Abstract][Full Text] [Related]
11. Roles and regulation of serine/threonine-specific protein phosphatases in the cell cycle.
Berndt N
Prog Cell Cycle Res; 2003; 5():497-510. PubMed ID: 14593745
[TBL] [Abstract][Full Text] [Related]
12. Dual-specificity phosphatases as targets for antineoplastic agents.
Lyon MA; Ducruet AP; Wipf P; Lazo JS
Nat Rev Drug Discov; 2002 Dec; 1(12):961-76. PubMed ID: 12461518
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of phosphatase inhibitors.
Vintonyak VV; Antonchick AP; Rauh D; Waldmann H
Curr Opin Chem Biol; 2009 Jun; 13(3):272-83. PubMed ID: 19410499
[TBL] [Abstract][Full Text] [Related]
14. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
Pollack SJ; Lewis H
Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
[TBL] [Abstract][Full Text] [Related]
15. [Protein phosphatase 2A: its structure, function and activity regulation].
Liu WJ; Shen Y; Ding J
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):105-12. PubMed ID: 12545214
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
17. Challenges and opportunities in the development of protein phosphatase-directed therapeutics.
De Munter S; Köhn M; Bollen M
ACS Chem Biol; 2013 Jan; 8(1):36-45. PubMed ID: 23214403
[TBL] [Abstract][Full Text] [Related]
18. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH
Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatases: structures and implications.
Jia Z
Biochem Cell Biol; 1997; 75(1):17-26. PubMed ID: 9192069
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease: from pathology to therapeutic approaches.
Jakob-Roetne R; Jacobsen H
Angew Chem Int Ed Engl; 2009; 48(17):3030-59. PubMed ID: 19330877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
